Brought to you by 
Inverness Medical signs preliminary deal to buy Concateno
14 Aug 2009
Executive Summary
Inverness Medical Innovations has proposed to acquire public UK drug and alcohol testing firm Concateno PLC for approximately £125mm ($203mm) in cash and stock.
Deal Industry
- In Vitro Diagnostics
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Saliva-based Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness Medical signs preliminary deal to buy Concateno
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice